257 related articles for article (PubMed ID: 34080789)
1. Type 2 diabetes mellitus duration and obesity alter the efficacy of autologously transplanted bone marrow-derived mesenchymal stem/stromal cells.
Nguyen LT; Hoang DM; Nguyen KT; Bui DM; Nguyen HT; Le HTA; Hoang VT; Bui HTH; Dam PTM; Hoang XTA; Ngo ATL; Le HM; Phung NY; Vu DM; Duong TT; Nguyen TD; Ha LT; Bui HTP; Nguyen HK; Heke M; Bui AV
Stem Cells Transl Med; 2021 Sep; 10(9):1266-1278. PubMed ID: 34080789
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study.
Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A
Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
[TBL] [Abstract][Full Text] [Related]
4. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
[TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from bone marrow mesenchymal stem cells harvested from type two diabetes rats promotes neurorestorative effects after stroke in type two diabetes rats.
Venkat P; Zacharek A; Landschoot-Ward J; Wang F; Culmone L; Chen Z; Chopp M; Chen J
Exp Neurol; 2020 Dec; 334():113456. PubMed ID: 32889008
[TBL] [Abstract][Full Text] [Related]
6. Towards Standardized Stem Cell Therapy in Type 2 Diabetes Mellitus: A Systematic Review.
Pawitan JA; Yang Z; Wu YN; Lee EH
Curr Stem Cell Res Ther; 2018; 13(6):476-488. PubMed ID: 29732994
[TBL] [Abstract][Full Text] [Related]
7. Characterisation and Expression of Osteogenic and Periodontal Markers of Bone Marrow Mesenchymal Stem Cells (BM-MSCs) from Diabetic Knee Joints.
Hussein N; Meade J; Pandit H; Jones E; El-Gendy R
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474098
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?
Azizi Z; Abbaszadeh R; Sahebnasagh R; Norouzy A; Motevaseli E; Maedler K
Stem Cell Res Ther; 2022 Jul; 13(1):348. PubMed ID: 35883121
[TBL] [Abstract][Full Text] [Related]
9. Safety and biodistribution study of bone marrow-derived mesenchymal stromal cells and mononuclear cells and the impact of the administration route in an intact porcine model.
Mäkelä T; Takalo R; Arvola O; Haapanen H; Yannopoulos F; Blanco R; Ahvenjärvi L; Kiviluoma K; Kerkelä E; Nystedt J; Juvonen T; Lehenkari P
Cytotherapy; 2015 Apr; 17(4):392-402. PubMed ID: 25601140
[TBL] [Abstract][Full Text] [Related]
10. The nuclear factor erythroid 2-related factor 2 agonist tert-butylhydroquinone improves bone marrow mesenchymal stromal cell function in prolonged isolated thrombocytopenia after allogeneic haematopoietic stem cell transplantation.
Luo XY; Kong Y; Lv M; Mo XD; Wang Y; Xu LP; Zhang XH; Huang XJ; Tang FF
Br J Haematol; 2023 Mar; 200(6):759-768. PubMed ID: 36464324
[TBL] [Abstract][Full Text] [Related]
11. Umbilical cord extracts improve diabetic abnormalities in bone marrow-derived mesenchymal stem cells and increase their therapeutic effects on diabetic nephropathy.
Nagaishi K; Mizue Y; Chikenji T; Otani M; Nakano M; Saijo Y; Tsuchida H; Ishioka S; Nishikawa A; Saito T; Fujimiya M
Sci Rep; 2017 Aug; 7(1):8484. PubMed ID: 28814814
[TBL] [Abstract][Full Text] [Related]
12. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
[TBL] [Abstract][Full Text] [Related]
14. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
[TBL] [Abstract][Full Text] [Related]
15. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II).
Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Núñez-Córdoba JM; López-Elío S; Andreu E; Sánchez-Guijo F; Aquerreta JD; Bondía JM; Valentí-Azcárate A; Del Consuelo Del Cañizo M; Villarón EM; Valentí-Nin JR; Prósper F
J Transl Med; 2018 Jul; 16(1):213. PubMed ID: 30064455
[TBL] [Abstract][Full Text] [Related]
17. Phase II multicenter randomized controlled clinical trial on the efficacy of intra-articular injection of autologous bone marrow mesenchymal stem cells with platelet rich plasma for the treatment of knee osteoarthritis.
Lamo-Espinosa JM; Blanco JF; Sánchez M; Moreno V; Granero-Moltó F; Sánchez-Guijo F; Crespo-Cullel Í; Mora G; San Vicente DD; Pompei-Fernández O; Aquerreta JD; Núñez-Córdoba JM; Vitoria Sola M; Valentí-Azcárate A; Andreu EJ; Del Consuelo Del Cañizo M; Valentí-Nin JR; Prósper F
J Transl Med; 2020 Sep; 18(1):356. PubMed ID: 32948200
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study.
Zhang L; Lai X; Guo Y; Ma J; Fang J; Li G; Xu L; Yin W; Chen Z
Ren Fail; 2021 Dec; 43(1):1266-1275. PubMed ID: 34493167
[TBL] [Abstract][Full Text] [Related]
20. Scaffold-based delivery of autologous mesenchymal stem cells for mandibular distraction osteogenesis: preliminary studies in a porcine model.
Sun Z; Tee BC; Kennedy KS; Kennedy PM; Kim DG; Mallery SR; Fields HW
PLoS One; 2013; 8(9):e74672. PubMed ID: 24040314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
